MedTrace Logo

COVID-19 and Vitamin D: Length of Hospital Stay and Mortality

NCT05221983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2022-02-21

No results posted yet for this study

Summary

The lack of a pharmacological treatment in the COVID-19 pandemic has pushed scientists to search for this issue. Maintaining optimal health is parallel to adequate and balanced nutrition. In this context, can the protective properties of vitamin D play an important role in this pandemic? brought with it the thought. In this study, it was aimed to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease.

Conditions

  • COVID-19 Pandemic
  • Vitamin D Deficiency

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    collaborator OTHER

  • Yuksek Ihtisas University

    lead OTHER

Principal Investigators

  • Levent Öztürk, MD · Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-21
Primary Completion
2021-11-09
Completion
2021-11-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05221983 on ClinicalTrials.gov